GeneXpert® System with Touchscreen

Transforming Point-of-Care Testing

Point-of-Care (POCT) enables the effective decentralisation of laboratory-standard diagnostics, which supports efficient patient management and in turn has the potential to enable NHS healthcare systems and Integrated Care Boards (ICBs) to meet growing testing demands.1 Multiplex PCR testing of respiratory viruses at the point of care is one example of this, and is particularly critical during the winter seasons with multiple circulating viruses, contributing to more effective handling for the sharp uptake of patients seen in emergency departments during this period.1 

 

 

Why Decentralise to Point-of-Care with Fast PCR for Respiratory Viruses?

Fast and accurate PCR diagnostics with Cepheid’s GeneXpert system with touchscreen and Xpert® Xpress CoV-2/Flu/RSV plus provide 24/7 on-demand, simple-to-use, and actionable results in 36 minutes for both point-of-care users and laboratory biomedical scientists. This helps to improve diagnostic access and patient outcomes, optimise infection control, and minimise avoidable healthcare costs.2,3

Virus coverage

Single test for SARS-CoV-2, Flu A, Flu B, and RSV with extended coverage to prevent impact of circulating mutations

Fast results

Results in 36 minutes for fast decision making to improve patient and bed management and patient safety

Easy workflow

<1-minute hands-on-time, random-access testing across both laboratory and point of care for results when needed most

 

Point-of-Care Testing for Respiratory Viruses with Cepheid

“It is important to identify whether a patient has a flu, RSV or COVID-19 to be able to treat patients correctly. Having the four targets in one cartridge meant you did not have to swab a patient multiple times; that you could run multiple tests at the same time. Point of care testing helps increase the flow of patients entering hospitals with results accurate and reliable”

 

Helen Peat

HCPC Registered Biomedical Scientist 

Cepheid's GeneXpert system, empowered with 10‑colour technology, offers a modern and rich user experience, and is now even easier to use in healthcare settings; a true point of care solution. The new GeneXpert system with touchscreen features an intuitive user interface to input tests and visualise results (including CT and PCR curves), reduced footprint, and extended connectivity. 

Lab in a Cartridge™ technology enables simple sample-to-answer testing with a self-contained, single-use test cartridge that automates nucleic acid extraction, PCR amplification, and target sequence detection.

GeneXpert system technology is the same across laboratory, emergency department and other critical sites of care, streamlining the diagnostic testing process closer to the patient while maintaining truly laboratory-standard testing and monitoring, further supporting quality of care. The standardised diagnostic model is well aligned to NHS pathology network hub and spoke essential services laboratory models, and to future NHS decentralisation reform to deliver new models of care.4

 

Seamless Connectivity

The GeneXpert system with touchscreen can be connected to LIS, middleware, or POC Data Manager, with automated pre- and post-analytical data processing.

  • Connectivity: Automate pre- and post-analytical data processing with built-in interface options for HL7, ASTM, and POCT1‑A2 CLSI communication standards
  • Easy Connection to Your Infrastructure: Connect your GeneXpert with Ethernet or WiFi
  • Secure Your Data: Single-app User Interface and Windows 10 with extended support (LTSC) offer increased system security and data privacy. Enable data encryption capabilities with the embedded Trusted Platform Module (TPM)
  • Remote Support: Integrated remote access button to enable secure on‑demand remote support with Cepheid Technical Support
  • Remote System Monitoring: Real-time tracking of instrument utilisation and performance with our cloud-based monitoring system, Cepheid 360
 

 

Choose Cepheid as your Trusted Diagnostic NHS Partner Today

Over the last 28 years, Cepheid has partnered with many hospitals, clinics, and laboratories around the world with more than 40,000 systems installed and
millions of tests performed, including ~2 million PCR tests delivered to NHS hospitals each year5, changing the lives of patients.

 

With our solutions, your healthcare organisation can potentially reduce costs, streamline operations, and maximise productivity while prioritising patient health.

 

Download POCT Infographic

Arrange your free demo

I would like to be part of the Cepheid Community and I understand and consent to receive information about products and services, invitations to virtual and in-person events such as workshops and webinars and educational content from Cepheid and similar information from Cepheid’s affiliates and representatives.

*required fields
Cepheid respects your privacy, and values the relationship with our customers, partners, and associates. Your personal data may be processed by Cepheid, its affiliates, representatives and other Danaher companies for business and marketing purposes. You can review Cepheid Privacy Policy online for additional information on your rights and how we use and share personal data we collect on our websites and other channels. Your consent to receiving Cepheid news can be withdrawn at any time. Building a relationship of trust is important to us and we will happily help with any questions on your personal data processing addressed to Privacy.officer@cepheid.com

CE-IVD. In Vitro Diagnostic Medical Device. May not be available in all countries.

1. Pathology in Practice. December 2024. Prepare for winter with POC multiplexed PCR respiratory testing. https://content.yudu.com/web/1u0jl/0A1v7oc/PiP-December-2024/html/index.html?page=22&origin=reader 

2. Brendish NJ, et al. Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study. Lancet Respir Med. 2020 Dec;8(12):1192-1200
3. Hinson JS, et al. Targeted rapid testing for SARS-CoV-2 in the emergency department is associated with large reductions in uninfected patient exposure time. J Hosp Infect. 2021 Jan;107:35-39.

4. Gov UK. Independent investigation of the NHS in England. Lord Darzi's report on the state of the National Health Service in England. https://www.gov.uk/government/publications/independent-investigation-of-the-nhs-in-england

5. 2023 Internal data analysis actual 1.9.

About Cepheid

Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility. The company's GeneXpert® systems and Xpert® tests automate highly complex and time-consuming manual procedures, providing A Better Way for institutions of any size to perform world-class PCR testing. Cepheid's broad test portfolio spans respiratory infections, blood virology, women's and sexual health, TB and emerging infectious diseases, healthcare-associated infectious diseases, oncology and human genetics. The company's solutions deliver actionable results where they are needed most from central laboratories and hospitals to near patient settings.

For more information, visit www.cepheid.com

© 2025 Cepheid. All Rights Reserved.